Maldives Blood Services launches nucleic acid testing for donated blood
Nucleic Acid Testing is used to detect infections such as Hepatitis B, Hepatitis C and HIV in donated blood.
Top Stories
-
3 arrested over attempt to smuggle over 1kg drugs into Maldives
-
Pharmacies asked to stock 80% of essential medicines in 6 months
-
No charges filed in death of worker at Thilafushi WAMCO site
-
MFDA warns against weight-loss products with misleading claims
-
President removes Savaahili from Addu council jurisdiction
Maldives Blood Services (MBS) has launched Nucleic Acid Testing (NAT) to screen donated blood for infectious diseases.
The service was introduced on Thursday at Maldives Blood Services under the Malé City Group of Hospitals.
Speaking at the launch, Chief Executive Officer Abdul Razzaq Haleem said the introduction of NAT marked an important step in strengthening blood services in the Maldives.
Nucleic Acid Testing is used to detect infections such as Hepatitis B, Hepatitis C and HIV in donated blood. The technology can identify these infections earlier than conventional screening methods, helping to improve the safety of blood transfusions.
Haleem said the introduction of the service would support efforts to align the country's blood services with international standards.
He added that the service also contributes to achieving the national standards for blood services and the objectives set out in the Maldives Thalassaemia Master Plan 2024–2034.
